UPDATE: Morgan Stanley Raises Price Target on CVS to $47

Loading...
Loading...
According to Morgan Stanley, CVS/Caremark
CVS
price target is increased to $47. Morgan Stanley said that margin expansion and what we expect to be another strong selling season should support current multiples. “Our new $47 price target assumes current 14.5 multiple applied to our CY12 forecast of $3.25. Our CY13 estimate of $3.77 is ~4% higher then consensus reflecting our assumptions regarding an accelerating benefit from generics in next 18-months.” CVS/Caremark closed on Friday at $40.78.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...